TNON:NASDAQTenon Medical, Inc. Analysis
Data as of 2026-09-06 - not real-time
$3.72
Latest Price
9/10Risk
Risk Level: High
Executive Summary
The moving-average structure behind Tenon Medical, Inc. is bearish at $3.72, with short-term averages lagging the long-term ones. Over a rolling month the price has lost 44.1%. RSI sits at 37.1, which reads as approaching oversold, and MACD momentum is bearish. Watch $3.62 as support and $17.84 as the nearer resistance level.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Consensus targets land 1092.9% above where the shares trade now. Revenue is growing at 126.8% on a -257.9% profit margin.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 300.0%, a beta of 0.98 and a maximum drawdown of 91.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Timeframes disagree: the short-term read is sell while the long-term read is hold, conviction 2 out of 10.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Consensus targets land 1092.9% above where the shares trade now. Revenue is growing at 126.8% on a -257.9% profit margin.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 300.0%, a beta of 0.98 and a maximum drawdown of 91.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Timeframes disagree: the short-term read is sell while the long-term read is hold, conviction 2 out of 10.
Top Market Events
~ Second Quarter 2026 Revenue of $1.3 Million, a 127% Increase Compared to Prior Year ~~ Second Quarter Gross Profit of...LOS GATOS, CA / ACCESS Newswire / July 30, 2026 / Tenon Medical, Inc.Tenon Medical Inc. TNON shares surged 82.86% to $0.64 after the bell on Thursday. According to Benzinga Pro data, the...
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 4/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 23.72
- MACD momentum is negative
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 23.72
- Analyst targets imply +1092.9% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- Negative profit margin of -257.9%
- Analyst targets imply +1092.9% versus the current price
- Negative return on equity of -551.2%
Key Metrics & Analysis
Financial Health
Revenue Growth126.80%
Profit Margin-257.85%
P/E Ratio-0.3
ROE-551.19%
ROA-71.98%
P/B Ratio-0.3
Op. Cash Flow$-11766000
Free Cash Flow$-6116125
Industry P/E30.6
Technical Analysis
TrendBearish
RSI37.1
Support$3.62
Resistance$17.84
MA 20$5.64
MA 50$7.13
MA 200$23.72
MACDBearish
VolumeDecreasing
Fear & Greed Index95.48
Valuation
Target Price$44.38
Upside/Downside1092.88%
GradeFair
TypeGrowth
Risk Assessment
Beta0.98
Volatility300.05%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.